Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Nordic Capital makes majority investment in ActiveViam, provider of advanced analytics for financial institutions



  • The investment is made in partnership with ActiveViam’s founders and management to support and accelerate continued high-growth and expansion               
  • Nordic Capital, a leading investor in banking software, will leverage its long-standing expertise and experience from accelerating digitization of the financial services industry
  • The aim is to realize ActiveViam’s potential of improving the ever-growing needs of financial institutions’ regulatory compliance and real-time monitoring — as well as deep historical analysis — of performance, risk management and financial planning

NEW YORK, Feb. 28, 2024 /PRNewswire/ — Nordic Capital announced today it has acquired a majority stake in ActiveViam to support its next phase of growth. The investment is made in close partnership with ActiveViam’s founders and management who will invest alongside Nordic Capital.

ActiveViam is a leading provider of advanced analytics and decision-making solutions for financial institutions, including risk analytics and regulatory compliance software. The technology is purpose-built, scalable and handles massive datasets in sub-seconds. Founded in 2005 by industry experts, ActiveViam understands the data analytics faced by financial institutions across trading desks, risk and compliance, and its track differentiated core technology outperforms horizontal data aggregation and analytics tools.

ActiveViam serves a wide range of financial services organizations: Tier 1 and Tier 2 banks, hedge funds, asset managers, exchanges and regulators. The Company has lined up an extensive group of technology, system integrator, go-to-market and OEM partners, including Google, Accenture, AWS, Deloitte, ClickHouse, S&P Global, Snowflake, and Wolters Kluwer.

Financial analytics is a $10.4 billion addressable market growing at 13 percent a year, according to L.E.K. Consulting. Market drivers include continuous regulatory change, a focus on automation of manual processes, and an increasing need for a unified view of data spread across the fragmented IT ecosystem typical for large financial institutions.

As an experienced investor in the banking software sector, Nordic Capital aims to leverage its extensive expertise to scale the continued high organic growth of ActiveViam, by investing in the organization, driving continued excellence in R&D and new products, and by supporting partnerships and M&A.

Emil Anderson, Partner, Nordic Capital Advisors, said: “We are impressed by the ActiveViam team and what they have achieved:  they empower financial organizations to reduce risk and increase revenue by making better decisions, faster. Forty percent of Tier 1 banks worldwide work with ActiveViam technology, and the company has an especially strong footprint in Europe and North America.  With Nordic Capital’s prior experience in banking software, network of senior advisors, and internal operations resources, Nordic Capital is well positioned to support ActiveViam in its next stage of growth. Nordic Capital is excited about partnering with the founders and management to continue the company’s remarkable growth journey.”

Kathy Perrotte, CEO and Co-Founder, ActiveViam, said, “Nordic Capital’s investment is a great opportunity for ActiveViam and great news for our clients, partners and employees. As a large and respected private equity investor, Nordic Capital deploys its significant operational expertise, strategic capabilities and inventive approach to accelerate the growth of the technology leaders it invests in.  Nordic Capital recognizes the power, speed and flexibility of the technology our team has created for our financial services clients, and we look forward to their support as we make further advancements and explore acquisition opportunities.”

Nordic Capital has over 30 years’ experience of accelerating growth of innovative technology companies and is set to leverage its deep sub-sector and operational knowledge to create value and further boost the Company’s ambitious growth plans. As a leading specialized Technology & Payments investor globally, Nordic Capital has to date made 29 technology investments in companies with an aggregate enterprise value of close to EUR 24 billion.

As part of the transaction, Guidepost Growth Equity, which first invested in ActiveViam in 2019, will sell all its shares.

Raymond James was the exclusive financial advisor to ActiveViam on this transaction, and Broadhaven acted as financial advisor to Nordic Capital.

The parties have agreed that the terms of the transaction will not be disclosed. The transaction was completed on February 27, 2024.

About ActiveViam

ActiveViam is a pure player specializing in risk data analytics for the financial services sector, one of the fastest moving and most regulated industries. The Company has approximately 160 employees across offices in New York, London, Singapore, Sydney, Hong Kong, Paris and Frankfurt.  ActiveViam has pioneered the use of high-performance analytics in finance, helping the largest investment banks, asset managers and hedge funds make better decisions, explain results with confidence, and simulate the impact of their decisions. ActiveViam’s mission is to deliver train-of-thought analysis on terabytes of data in the most cost-effective way so its customers can explain their results with confidence and model the scenarios that will optimize their business. For more information please visit:

About Nordic Capital

Nordic Capital is a leading sector-specialist private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history. Focus sectors are Healthcare, Technology & Payments, Financial Services, and Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested EUR 23 billion in 140 investments. The most recent entities are Nordic Capital XI with EUR 9.0 billion in committed capital and Nordic Capital Evolution with EUR 1.2 billion in committed capital, principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, the UK, the US, Germany, Denmark, Finland, Norway, and South Korea. For further information about Nordic Capital, please visit

“Nordic Capital” refers to, depending on the context, any, or all, Nordic Capital branded entities, vehicles, structures, and associated entities. The general partners and/or delegated portfolio managers of Nordic Capital’s entities and vehicles are advised by several non-discretionary sub-advisory entities, any or all of which are referred to as “Nordic Capital Advisors.”

Media contacts:

Nordic Capital
Katarina Janerud
Communications Manager, Nordic Capital Advisors
Tel: +46 8 440 50 50
e-mail: [email protected]

US media contact – Brunswick Group
[email protected]


Erica Fidel
Vice President, Marketing
Tel: +1 646 688 4442
e-mail: [email protected]

Hilary Condit
Communications Consultant
Tel: +1 914 886 5027
[email protected]

The following files are available for download:


View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading